This was demonstrated by the upregulated expression of FAS in the patients with SLE (FC 2.0 in the CD4+ T cells, FC 1.8 in the CD16− monocytes and FC 1.3 in the CD16+ monocytes) (Table S4). The gene discussed is FAS; the disease is systemic lupus erythematosus.